Author:
Rieck M,Schumacher-Schuh A F,Altmann V,Callegari-Jacques S M,Rieder C R M,Hutz M H
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology,Genetics,Molecular Medicine
Reference33 articles.
1. Alves G, Forsaa EB, Pedersen KF, Dreetz Gjerstad M, Larsen JP . Epidemiology of Parkinson’s disease. J Neurol 2008; 255: 18–32.
2. Schapira AHV . The clinical relevance of levodopa toxicity in the treatment of Parkinson’s disease. Mov Disord 2008; 23: S515–S520.
3. Olanow CW, Agid Y, Mizuno Y, Albanese A, Bonuccelli U, Bonucelli U et al. Levodopa in the treatment of Parkinson’s disease: current controversies. Mov Disord 2004; 19: 997–1005.
4. Olanow CW, Lees A, Obeso J . Levodopa therapy for Parkinson’s disease: challenges and future prospects. Mov Disord 2008; 23: S495–S496.
5. Poewe W, Antonini A, Zijlmans JC, Burkhard PR, Vingerhoets F . Levodopa in the treatment of Parkinson’s disease: an old drug still going strong. Clin Interv Aging 2010; 5: 229–238.
Cited by
20 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献